Sign in
8-K

Current Report

IONIS PHARMACEUTICALS INC Filed Acc 0001140361-21-011725

Exit or restructuring costs

  • Item 2.05 Costs associated with exit or disposal activities

From the SEC's structured data for this filing

Loading brhc10022825_8k.htm…